Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.22.1
Cover - shares
 3 Months Ended
Mar. 31, 2022
May 06, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 000-24249  
Entity Registrant Name Interpace Biosciences, Inc.  
Entity Central Index Key 0001054102  
Entity Tax Identification Number 22-2919486  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One Morris Corporate Center 1  
Entity Address, Address Line Two Building C  
Entity Address, Address Line Three 300 Interpace Parkway  
Entity Address, City or Town Parsippany  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 07054  
City Area Code (855)  
Local Phone Number 776-6419  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   4,229,939